Today Alessia Maranesi successfully defended her PhD thesis “Elucidating the Potential of Antimicrobial Peptides through Biomaterials and Advanced In Vitro Models.” The Stop Spread Bad Bugs Consortium congratulates her with

Beyond the Nursery: Why Poultry is the New Frontier for HMOs Usually, when people hear the words “Human Milk Oligosaccharides” (HMOs), they think of nursery rhymes and sleepy babies. And

How bacteria survive antibiotics: Resistance, Tolerance and Persistence. Have you ever wondered how sometimes, after a “killer dose” of antibiotics, a small fraction of bacteria just… hang on? And no,

The Battle at the Biomaterial Interface: Immune Dysregulation, Infection and Next-Gen Responsive Materials How our immune system welcomes implantable materials Upon implanting a (bio)material, the host’s immune system is activated,

One of the SSBB Doctoral Candidates published a review about the mechanisms, effects, and applications of HMOs and polyphenols in allergies. In this review, we outline the basic biology of

Today was a very special day for the Stop Spread Bad Bugs Consortium. We had the joy of celebrating Saha Satvati’s PhD defense at the Università di Siena, where she

As part of his training in Liège, Belgium, Jarod Farruggia participated in a nationwide competition, “My thesis in 180 seconds”. This event invites the participants to explain in simple terms

We are proud to announce that Felipe Gama Franceschi has been selected to participate in the 75th Lindau Nobel Laureate Meeting! This Lindau Nobel Laureate Meeting is an interdisciplinary meeting

The SSBB project have published the results from a collaborative study of different consortium partners. In this study, the potential of biosynthesized cellulose membranes as drug carriers to present antimicrobial

When we think of bacteria, we often imagine free-floating single cells that can be eliminated with antibiotics or disinfectants. In reality, many bacteria prefer to live in communities, called biofilms- slimy, structured layers that adhere to

Innovative approaches against bacterial infection are a vital necessity. Nowadays, most of the antibiotics on the market are targeting one single bacterial process to take them down, leading to a

SSBB researchers have tested the ability of the synthetic antimicrobial peptide SET-M33 to target porcine respiratory pathogens and a collection of porcine commensal nasal microbiota members in vitro. The experiments

As part of the SSBB Career Development Program, Saha and Ana recently spent an inspiring week at the Research Development Office (RDO) of Erasmus MC in Rotterdam. The visit offered

InBiose, founded in 2013 as a spinoff from the University of Ghent, is now the biggest private research group in the world of specialty glycan. It is a leading B2B

Molecular dynamics (MD) is a powerful computational tool used to model biological processes and explore their mechanisms at the atomic/molecular level. This technique has enabled us to investigate atom-to-atom interactions

Antimicrobial resistance (AMR) is a global health emergency that already causes over 1.2 million deaths every year. But here’s the good news: AI-driven drug discovery is no longer a promise,

The antimicrobial peptides (AMPs) SET-M33L and SET-M33L-PEG were investigated against 10 clinical isolates of P. aeruginosa. Their minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), and minimum biofilm inhibitory concentrations (MBICs)

Before any treatment becomes available to patients, it must be proven to be both effective and safe. This involves a long (often 10-15 years), complex and multi-stage process of drug

Antimicrobial resistance, or AMR, is often called a “silent pandemic” because it is happening quietly all around us. It occurs when bacteria learn how to survive the medicines that once

Antimicrobial resistance (AMR) is growing into one of the most significant public health challenges of our time. The World Health Organization claims it is among the main public health threats in the history.   🔬 What

Four SSBB doctoral candidates from three different partners worked together and published a paper about the efficacy of the SET-M33 antimicrobial peptide in combination with different implant materials that enter

During January and February 2025, Ismael Castañón carried out research at Hylomorph as part of a collaborative project between Hylomorph (Switzerland) and SetLance (Italy), focused on the development of dual-affinity

From January 22nd to 24th, the 4th Consortium Meeting of the Stop Spread Bad Bugs project and PhD training took place at Erasmus MC! Our PhD researchers, alongside our partners,

From July 22nd to August 2nd, Alessia Maranesi visited Erasmus Medical Center (EMC) in Rotterdam. There she collaborated with Sajad Mohammadi, a PhD candidate at EMC exploring the antimicrobial efficacy

On June 14, 2024 Erasmus MC organized the mini-symposium “Clearing our view on tissue microenvironments” to discuss novel approaches to study (immune) cell dynamics in tissues. A wide spectrum of

From April 2 to May 10, 2024, Ariana Carvalho visited the Medical University of Vienna (MUW). She presented her PhD project at the Institute of Pathophysiology and Allergy Research, MUW

On April 15th and 16th 2024 the third consortium meeting of the Stop Spread Bag Buds consortium took place at Trinity College Dublin in Ireland. Over these days participants engaged

SSBB researchers published a comprehensive review informing and guiding researchers about the latest developments in antimicrobial peptides (AMP) research, presenting promising evidence of the role of AMPs as effective antimicrobial

From January 9 to 19, 2024, Alessio Fontanot visited the Medical University of Vienna (MUW). He worked with Mike from TissueGnostics GmbH (TG) and Isabella (MUW) on image analysis of

On September 21st and 22nd 2023 the Mid-Term meeting of the Stop Spread Bag Buds consortium took place at TissueGnostics GmbH in Vienna, Austria. This was the first meeting where

On 18th and 19th January 2023 the kick-off meeting of the Stop Spread Bad Bugs consortium took place in Hotel New York in Rotterdam. The meeting was a great occasion